156 related articles for article (PubMed ID: 18336532)
1. Serum FLT-3 ligand in a busulphan-induced model of chronic bone marrow hypoplasia in the female CD-1 mouse.
Molyneux G; Gibson FM; Whayman M; Turton JA
Int J Exp Pathol; 2008 Apr; 89(2):159-70. PubMed ID: 18336532
[TBL] [Abstract][Full Text] [Related]
2. The haemotoxicity of mitomycin in a repeat dose study in the female CD-1 mouse.
Molyneux G; Gibson FM; Gordon-Smith EC; Pilling AM; Liu KC; Rizzo S; Sulsh S; Turton JA
Int J Exp Pathol; 2005 Dec; 86(6):415-30. PubMed ID: 16309546
[TBL] [Abstract][Full Text] [Related]
3. The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse.
Molyneux G; Gibson FM; Chen CM; Marway HK; McKeag S; Mifsud CV; Pilling AM; Whayman MJ; Turton JA
Int J Exp Pathol; 2008 Apr; 89(2):138-58. PubMed ID: 18336531
[TBL] [Abstract][Full Text] [Related]
4. Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse.
Turton JA; Sones WR; Andrews CM; Pilling AM; Williams TC; Molyneux G; Rizzo S; Gordon-Smith EC; Gibson FM
Int J Exp Pathol; 2006 Feb; 87(1):49-63. PubMed ID: 16436113
[TBL] [Abstract][Full Text] [Related]
5. Modulation of haematopoietic progenitor development by FLT-3 ligand.
Banu N; Deng B; Lyman SD; Avraham H
Cytokine; 1999 Sep; 11(9):679-88. PubMed ID: 10479404
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice.
Sudo Y; Shimazaki C; Ashihara E; Kikuta T; Hirai H; Sumikuma T; Yamagata N; Goto H; Inaba T; Fujita N; Nakagawa M
Blood; 1997 May; 89(9):3186-91. PubMed ID: 9129021
[TBL] [Abstract][Full Text] [Related]
7. Haemotoxicity of busulphan, doxorubicin, cisplatin and cyclophosphamide in the female BALB/c mouse using a brief regimen of drug administration.
Molyneux G; Andrews M; Sones W; York M; Barnett A; Quirk E; Yeung W; Turton J
Cell Biol Toxicol; 2011 Feb; 27(1):13-40. PubMed ID: 20589437
[TBL] [Abstract][Full Text] [Related]
8. The role of RIP1 and RIP3 in the development of aplastic anemia induced by cyclophosphamide and busulphan in mice.
Chen YF; Zhao ZQ; Wu ZM; Zou ZY; Luo XJ; Li J; Xie C; Liang Y
Int J Clin Exp Pathol; 2014; 7(12):8411-20. PubMed ID: 25674205
[TBL] [Abstract][Full Text] [Related]
9. O6-Benzylguanine potentiates BCNU but not busulfan toxicity in hematopoietic stem cells.
Westerhof GR; Down JD; Blokland I; Wood M; Boudewijn A; Watson AJ; McGown AT; Ploemacher RE; Margison GP
Exp Hematol; 2001 May; 29(5):633-8. PubMed ID: 11376877
[TBL] [Abstract][Full Text] [Related]
10. Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit.
Jin L; Neff T; Blau CA
Exp Hematol; 1999 Mar; 27(3):520-5. PubMed ID: 10089915
[TBL] [Abstract][Full Text] [Related]
11. A new model of busulphan-induced chronic bone marrow aplasia in the female BALB/c mouse.
Gibson FM; Andrews CM; Diamanti P; Rizzo S; Macharia G; Gordon-Smith EC; Williams T; Turton J
Int J Exp Pathol; 2003 Feb; 84(1):31-48. PubMed ID: 12694485
[TBL] [Abstract][Full Text] [Related]
12. Bone and bone-marrow interactions: haematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. Mobilizing properties on white blood cells and peripheral blood stem cells in mice.
Fazzi R; Testi R; Trasciatti S; Galimberti S; Rosini S; Piras F; L'Abbate G; Conte A; Petrini M
Leuk Res; 2002 Jan; 26(1):19-27. PubMed ID: 11734300
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
[TBL] [Abstract][Full Text] [Related]
14. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
Brasel K; McKenna HJ; Charrier K; Morrissey PJ; Williams DE; Lyman SD
Blood; 1997 Nov; 90(9):3781-8. PubMed ID: 9345066
[TBL] [Abstract][Full Text] [Related]
15. FLT-3 ligand mobilizes hematopoietic primitive and committed progenitor cells into blood in mice.
Ashihara E; Shimazaki C; Sudo Y; Kikuta T; Hirai H; Sumikuma T; Yamagata N; Goto H; Inaba T; Fujita N; Nakagawa M
Eur J Haematol; 1998 Feb; 60(2):86-92. PubMed ID: 9508348
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cells from the marrow of mice treated with Flt3 ligand are significantly expanded but exhibit reduced engraftment potential.
Mueller YM; Cramer DE; Huang Y; Exner BG; Ildstad ST
Transplantation; 2002 Apr; 73(8):1177-85. PubMed ID: 11981407
[TBL] [Abstract][Full Text] [Related]
17. The antineoplastic busulphan impairs peritubular and Leydig cells, and vitamin B
Sasso-Cerri E; Oliveira B; de Santi F; Beltrame FL; Caneguim BH; Cerri PS
Biomed Pharmacother; 2017 Nov; 95():1619-1630. PubMed ID: 28950662
[TBL] [Abstract][Full Text] [Related]
18. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen.
Sefc L; Psenák O; Sýkora V; Sulc K; Necas E
J Hematother Stem Cell Res; 2003 Feb; 12(1):47-61. PubMed ID: 12662436
[TBL] [Abstract][Full Text] [Related]
19. Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia.
Bertho JM; Demarquay C; Frick J; Joubert C; Arenales S; Jacquet N; Sorokine-Durm I; Chau Q; Lopez M; Aigueperse J; Gorin NC; Gourmelon P
Int J Radiat Biol; 2001 Jun; 77(6):703-12. PubMed ID: 11403710
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the hematopoietic activity of flt-3 ligand and granulocyte-macrophage colony-stimulating factor acting alone or in combination.
Robinson S; Mosley RL; Parajuli P; Pisarev V; Sublet J; Ulrich A; Talmadge J
J Hematother Stem Cell Res; 2000 Oct; 9(5):711-20. PubMed ID: 11091495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
